# RPM_DATA_ANOMALY_AND_ESCALATION_PROTOCOL.md

## 1. Purpose
This protocol defines the mandatory detection, classification, escalation, and resolution procedures for data anomalies within the NeuroGrid Remote Patient Monitoring (RPM) system. Its objective is to preserve data integrity, prevent unsafe clinical inference, and ensure timely human intervention.

## 2. Scope
This protocol applies to:
- Incoming RPM device telemetry
- Data transmission pipelines
- Data preprocessing and normalization layers
- Feature extraction outputs
- Downstream analytics and alerting systems
- Stored RPM datasets used for analysis or review

It applies to both real-time and batch data flows.

## 3. Definition of Data Anomaly
A data anomaly is any deviation that may:
- Distort clinical interpretation
- Degrade model or rule-based inference
- Mask or fabricate patient risk
- Indicate device malfunction or misuse
- Signal data corruption or tampering

Absence of expected data is treated as an anomaly.

## 4. Anomaly Categories

### 4.1 Signal-Level Anomalies
- Out-of-range values
- Physiologically implausible readings
- Flatline or saturation patterns
- Excessive noise or signal dropout

### 4.2 Temporal Anomalies
- Irregular sampling intervals
- Delayed or missing data packets
- Timestamp inconsistencies
- Clock drift beyond tolerance thresholds

### 4.3 Consistency Anomalies
- Cross-sensor disagreement
- Sudden baseline shifts
- Intra-patient pattern divergence
- Conflict with known clinical context

### 4.4 Systemic Anomalies
- Widespread data irregularities
- Pipeline processing failures
- Schema or format deviations
- Integrity check failures

## 5. Detection Mechanisms
Anomalies may be detected through:
- Automated validation rules
- Statistical deviation thresholds
- Cross-signal coherence checks
- Data integrity and checksum verification
- Manual clinician or operator reports

All detections must generate an anomaly event ID.

## 6. Anomaly Classification Levels

### Level A – Low
- Minor deviation
- No immediate clinical impact
- Monitoring required

### Level B – Moderate
- Potential clinical relevance
- Requires review and contextual validation

### Level C – High
- Likely to affect alerts or decisions
- Requires escalation and intervention

### Level D – Critical
- Immediate patient safety risk
- Possible data corruption or system failure
- Mandatory emergency response

## 7. Immediate Handling Rules
Upon anomaly detection:
- Affected data is flagged
- Automated clinical inference is suspended where required
- Human review is prioritized
- Downstream systems are notified of degraded data trust

Unsafe data must never propagate unmarked.

## 8. Escalation Path
Escalation proceeds as follows:
- Level A: Logged and monitored
- Level B: Reviewed by RPM operations team
- Level C: Escalated to clinical oversight and safety lead
- Level D: Immediate activation of incident response protocol

Escalation timelines are mandatory and enforceable.

## 9. Clinical Notification
For Level C and D anomalies:
- Clinicians are informed of data reliability concerns
- Alerts derived from affected data are labeled or suppressed
- Human judgment supersedes system output

Clinical awareness is mandatory.

## 10. Investigation Process
Each escalated anomaly requires:
- Root cause analysis
- Device and pipeline verification
- Data lineage inspection
- Determination of patient impact

Findings must be evidence-based and documented.

## 11. Resolution Actions
Resolution may include:
- Data correction or exclusion
- Device recalibration or replacement
- Pipeline remediation
- Model or rule adjustment
- Governance or compliance escalation

Resolution actions must be approved and logged.

## 12. Post-Resolution Validation
Before restoring normal operation:
- Data quality checks must pass
- Alert accuracy must be verified
- Confidence thresholds must be reconfirmed
- Human-in-the-loop controls must be active

Partial restoration is permitted only when safe.

## 13. Documentation and Recordkeeping
All anomaly events are:
- Logged immutably
- Timestamped
- Linked to affected data and systems
- Retained per data governance policies

Suppression or deletion of anomaly records is prohibited.

## 14. Continuous Improvement
Anomaly trends are periodically reviewed to:
- Improve detection mechanisms
- Refine escalation thresholds
- Enhance system robustness
- Inform governance and design changes

Repeated anomalies trigger heightened oversight.

## 15. Regulatory Alignment
This protocol aligns with:
- FDA post-market surveillance expectations
- EU AI Act data quality and monitoring requirements
- ISO/IEC data integrity standards
- Clinical governance best practices

## 16. Status
Active – Mandatory RPM Data Anomaly and Escalation Protocol

